First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19

Affiliations

¹ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
² Department of Anaesthesiology and Critical Care, University Medicine Bonn, Bonn, Germany.
³ Department of Nephrology and Hypertension, Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany. david.sascha@mh-hannover.de.

Comment

Klaus Stahl et al. Crit Care. 2020.

. 2020 Jun 18;24(1):363.

doi: 10.1186/s13054-020-03070-7.

¹ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
² Department of Anaesthesiology and Critical Care, University Medicine Bonn, Bonn, Germany.
³ Department of Nephrology and Hypertension, Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany. david.sascha@mh-hannover.de.

No abstract available

Conflict of interest statement

The authors declare that they have no competing interests.

A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.
Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. Keith P, et al. Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4. Crit Care. 2020. PMID: 32241301 Free PMC article. No abstract available.

1. Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19. Crit Care. 2020;24(1):128. doi: 10.1186/s13054-020-2836-4. - DOI - PMC - PubMed
1. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020. - PMC - PubMed
1. Stahl K, Schmidt JJ, Seeliger B, et al. Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock. Crit Care. 2020;24(1):71. doi: 10.1186/s13054-020-2799-5. - DOI - PMC - PubMed
1. Knaup H, Stahl K, Schmidt BMW, et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018;22(1):285. doi: 10.1186/s13054-018-2220-9. - DOI - PMC - PubMed
1. Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323(16):1582–9. 10.1001/jama.2020.478. - PMC - PubMed